CompletedNot applicableNCT03926845
Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation
Studying Disorder of melanin metabolism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institute of Dermatology, Thailand
- Principal Investigator
- Chinmanat Lekhavat, MDInstitute of Dermatology
- Intervention
- Isobutylamido-thiazolyl-resorcinol Cream 0.2%(other)
- Enrollment
- 200 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2021
Study locations (1)
- Institute of Dermatology, Ratchathewi, Bangkok, Thailand
Collaborators
Beiersdorf (Thailand) Co., Ltd.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03926845 on ClinicalTrials.govOther trials for Disorder of melanin metabolism
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07402720Clinical Effectiveness Of Polishing Brush Compared To Ceramic Soft Tissue Trimming Bur In Gingival DepigmentationCairo University
- ENROLLING BY INVITATIONNANCT07195539CO2 Fractional Laser With Tranexamic Acid As An Effective Tool For Post Burn Hyperpigmentation.King Edward Medical University
- RECRUITINGNANCT06491615National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic DiseasesNational Eye Institute (NEI)
- RECRUITINGNANCT06268496Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 OriginsCosmetique Active International
- RECRUITINGNCT06138509Peripheral Serotonin and AlbinismAssistance Publique - Hôpitaux de Paris